Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan

JPMorgan says Astellas Pharma’s (ALPMY) (ALMPY) announcement that the FDA has issued a Complete Response Letter regarding for Izervay in geographic atrophy is “clearly a positive” for Apellis’ (APLS) Syfovre.